TY - JOUR AU - Cerami, A. AU - Vlassara, H. AU - Brownlee, M. PY - 1986 DA - 1986// TI - Role of nonenzymatic glycosylation in atherogenesis JO - J Cell Biochem VL - 30 UR - https://doi.org/10.1002/jcb.240300203 DO - 10.1002/jcb.240300203 ID - Cerami1986 ER - TY - JOUR AU - Stitt, A. W. AU - Bucala, R. AU - Vlassara, H. PY - 1997 DA - 1997// TI - Atherogenesis and advanced glycation: promotion, progression, and prevention JO - Ann NY Acad Sci VL - 811 UR - https://doi.org/10.1111/j.1749-6632.1997.tb51994.x DO - 10.1111/j.1749-6632.1997.tb51994.x ID - Stitt1997 ER - TY - JOUR AU - Monnier, V. M. AU - Sell, D. R. AU - Genuth, S. PY - 2005 DA - 2005// TI - Glycation products as markers and predictors of the progression of diabetic complications JO - Ann NY Acad Sci VL - 1043 UR - https://doi.org/10.1196/annals.1333.065 DO - 10.1196/annals.1333.065 ID - Monnier2005 ER - TY - STD TI - López-Díez R, Shekhtman A, Ramasamy R, Schmidt AM. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity, Biochim Biophys Acta. 2016;doi:10.1016/j.bbadis.2016.05.005. ID - ref4 ER - TY - JOUR AU - Lin, R. Y. AU - Choudhury, R. P. AU - Cai, W. AU - Lu, M. AU - Fallon, J. T. AU - Fisher, E. A. AU - Vlassara, H. PY - 2003 DA - 2003// TI - Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice JO - Atherosclerosis VL - 168 UR - https://doi.org/10.1016/S0021-9150(03)00050-9 DO - 10.1016/S0021-9150(03)00050-9 ID - Lin2003 ER - TY - JOUR AU - Panagiotopoulos, S. AU - O'Brien, R. C. AU - Bucala, R. AU - Cooper, M. E. AU - Jerums, G. PY - 1998 DA - 1998// TI - Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit JO - Atherosclerosis VL - 136 UR - https://doi.org/10.1016/S0021-9150(97)00192-5 DO - 10.1016/S0021-9150(97)00192-5 ID - Panagiotopoulos1998 ER - TY - JOUR AU - Park, L. AU - Raman, K. G. AU - Lee, K. J. AU - Lu, Y. AU - Ferran, L. J. AU - Chow, W. S. AU - Stern, D. AU - Schmidt, A. M. PY - 1998 DA - 1998// TI - Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts JO - Nat Med VL - 4 UR - https://doi.org/10.1038/2012 DO - 10.1038/2012 ID - Park1998 ER - TY - JOUR AU - Bucciarelli, L. G. AU - Wendt, T. AU - Qu, W. AU - Lu, Y. AU - Lalla, E. AU - Rong, L. L. AU - Goova, M. T. AU - Moser, B. AU - Kislinger, T. AU - Lee, D. C. AU - Kashyap, Y. AU - Stern, D. M. AU - Schmidt, A. M. PY - 2002 DA - 2002// TI - RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice JO - Circulation VL - 106 UR - https://doi.org/10.1161/01.CIR.0000039325.03698.36 DO - 10.1161/01.CIR.0000039325.03698.36 ID - Bucciarelli2002 ER - TY - STD TI - Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes. 2008;57:2461–9. ID - ref9 ER - TY - JOUR AU - Nin, J. W. AU - Jorsal, A. AU - Ferreira, I. AU - Schalkwijk, C. G. AU - Prins, M. H. AU - Parving, H. H. AU - Tarnow, L. AU - Rossing, P. AU - Stehouwer, C. D. PY - 2011 DA - 2011// TI - Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study JO - Diabetes Care VL - 34 UR - https://doi.org/10.2337/dc10-1087 DO - 10.2337/dc10-1087 ID - Nin2011 ER - TY - JOUR AU - Kilhovd, B. K. AU - Juutilainen, A. AU - Lehto, S. AU - Rönnemaa, T. AU - Torjesen, P. A. AU - Hanssen, K. F. AU - Laakso, M. PY - 1997 DA - 1997// TI - Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study JO - Diabetologia VL - 50 UR - https://doi.org/10.1007/s00125-007-0687-z DO - 10.1007/s00125-007-0687-z ID - Kilhovd1997 ER - TY - JOUR AU - Yamagishi, S. PY - 2012 DA - 2012// TI - Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders JO - Rejuvenation Res VL - 15 UR - https://doi.org/10.1089/rej.2012.1335 DO - 10.1089/rej.2012.1335 ID - Yamagishi2012 ER - TY - JOUR AU - Yamagishi, S. AU - Fukami, K. AU - Matsui, T. PY - 2015 DA - 2015// TI - Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: a novel marker of vascular complications in high-risk patients for cardiovascular disease JO - Int J Cardiol VL - 185 UR - https://doi.org/10.1016/j.ijcard.2015.03.167 DO - 10.1016/j.ijcard.2015.03.167 ID - Yamagishi2015 ER - TY - JOUR AU - Yamagishi, S. AU - Matsui, T. PY - 2010 DA - 2010// TI - Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker JO - Front Biosci (Elite Ed) VL - 2 UR - https://doi.org/10.2741/e178 DO - 10.2741/e178 ID - Yamagishi2010 ER - TY - JOUR AU - Nerurkar, P. V. AU - Hwang, P. W. AU - Saksa, E. PY - 2015 DA - 2015// TI - Anti-diabetic potential of Noni: the Yin and the Yang JO - Molecules VL - 20 UR - https://doi.org/10.3390/molecules201017684 DO - 10.3390/molecules201017684 ID - Nerurkar2015 ER - TY - JOUR AU - Brown, A. C. PY - 2012 DA - 2012// TI - Anticancer activity of Morinda citrifolia (Noni) fruit: a review JO - Phytother Resl VL - 26 ID - Brown2012 ER - TY - STD TI - Yamagishi S, Matsui T, Ishibashi, Isami F, Abe Y, Sakaguchi T, Higashimoto Y. Phytochemicals against advanced glcation end products (AGEs) and the receptor system. Curr Pharm Des. 2016 (in press). ID - ref17 ER - TY - JOUR AU - Yamagishi, S. AU - Nakamura, K. AU - Matsui, T. AU - Inagaki, Y. AU - Takenaka, K. AU - Jinnouchi, Y. AU - Yoshida, Y. AU - Matsuura, T. AU - Narama, I. AU - Motomiya, Y. AU - Takeuchi, M. AU - Inoue, H. AU - Yoshimura, A. AU - Bucala, R. AU - Imaizumi, T. PY - 2006 DA - 2006// TI - Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M602110200 DO - 10.1074/jbc.M602110200 ID - Yamagishi2006 ER - TY - JOUR AU - Masuda, M. AU - Murata, K. AU - Fukuhama, A. AU - Naruto, S. AU - Fujita, T. AU - Uwaya, A. AU - Isami, F. AU - Matsuda, H. PY - 2009 DA - 2009// TI - Inhibitory effect of constituents of Morinda citrifolia seed on elastase and tyrosinase JO - J Nat Med VL - 63 UR - https://doi.org/10.1007/s11418-009-0328-6 DO - 10.1007/s11418-009-0328-6 ID - Masuda2009 ER - TY - JOUR AU - Ishibashi, Y. AU - Matsui, T. AU - Ueda, S. AU - Fukami, K. AU - Yamagishi, S. PY - 2014 DA - 2014// TI - Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression JO - Cardiovasc Diabetol VL - 13 UR - https://doi.org/10.1186/1475-2840-13-60 DO - 10.1186/1475-2840-13-60 ID - Ishibashi2014 ER - TY - JOUR AU - Matsui, T. AU - Nakamura, N. AU - Ojima, A. AU - Nishino, Y. AU - Yamagishi, S. I. PY - 2016 DA - 2016// TI - Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta JO - Nutr Metab Cardiovasc Dis VL - 26 UR - https://doi.org/10.1016/j.numecd.2016.04.008 DO - 10.1016/j.numecd.2016.04.008 ID - Matsui2016 ER - TY - JOUR AU - Lamon, B. D. AU - Hajjar, D. P. PY - 2008 DA - 2008// TI - Inflammation at the molecular interface of atherogenesis: an anthropological journey JO - Am J Pathol VL - 173 UR - https://doi.org/10.2353/ajpath.2008.080442 DO - 10.2353/ajpath.2008.080442 ID - Lamon2008 ER - TY - STD TI - Corte VD, Tuttolomondo A, Pecoraro R, Pinto A. Inflammation, endothelial dysfunction and arterial stiffness as therapeutic targets in cardiovascular medicine. Curr Pharm Des. 2016 (in press). ID - ref23 ER - TY - JOUR AU - Gimbrone, M. A. AU - García-Cardeña, G. PY - 2016 DA - 2016// TI - Endothelial cell dysfunction and the pathobiology of atherosclerosis JO - Circ Res VL - 118 UR - https://doi.org/10.1161/CIRCRESAHA.115.306301 DO - 10.1161/CIRCRESAHA.115.306301 ID - Gimbrone2016 ER - TY - JOUR AU - Yamagishi, S. AU - Imaizumi, T. PY - 2005 DA - 2005// TI - Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy JO - Curr Pharm Des VL - 11 UR - https://doi.org/10.2174/1381612054367300 DO - 10.2174/1381612054367300 ID - Yamagishi2005 ER - TY - JOUR AU - Yamagishi, S. PY - 2011 DA - 2011// TI - Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes JO - Exp Gerontol VL - 46 UR - https://doi.org/10.1016/j.exger.2010.11.007 DO - 10.1016/j.exger.2010.11.007 ID - Yamagishi2011 ER - TY - JOUR AU - Ojima, A. AU - Matsui, T. AU - Maeda, S. AU - Takeuchi, M. AU - Yamagishi, S. PY - 2012 DA - 2012// TI - Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties JO - Horm Metab Res VL - 44 UR - https://doi.org/10.1055/s-0032-1312595 DO - 10.1055/s-0032-1312595 ID - Ojima2012 ER - TY - JOUR AU - Ando, R. AU - Ueda, S. AU - Yamagishi, S. AU - Miyazaki, H. AU - Kaida, Y. AU - Kaifu, K. AU - Yokoro, M. AU - Nakayama, Y. AU - Obara, N. AU - Fukami, K. AU - Takeuchi, M. AU - Okuda, S. PY - 2013 DA - 2013// TI - Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial cells JO - Diab Vasc Dis Res VL - 10 UR - https://doi.org/10.1177/1479164113486662 DO - 10.1177/1479164113486662 ID - Ando2013 ER - TY - JOUR AU - Lawson, C. AU - Wolf, S. PY - 2009 DA - 2009// TI - ICAM-1 signaling in endothelial cells JO - Pharmacol Rep VL - 61 UR - https://doi.org/10.1016/S1734-1140(09)70004-0 DO - 10.1016/S1734-1140(09)70004-0 ID - Lawson2009 ER - TY - JOUR AU - Takenaka, K. AU - Yamagishi, S. AU - Matsui, T. AU - Nakamura, K. AU - Imaizumi, T. PY - 2006 DA - 2006// TI - Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes JO - Curr Neurovasc Res VL - 3 UR - https://doi.org/10.2174/156720206775541804 DO - 10.2174/156720206775541804 ID - Takenaka2006 ER - TY - JOUR AU - Matsui, T. AU - Nishino, Y. AU - Takeuchi, M. AU - Yamagishi, S. PY - 2011 DA - 2011// TI - Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis JO - Pharmacol Res VL - 63 UR - https://doi.org/10.1016/j.phrs.2011.02.003 DO - 10.1016/j.phrs.2011.02.003 ID - Matsui2011 ER - TY - JOUR AU - Xu, H. AU - Shen, J. AU - Liu, H. AU - Shi, Y. AU - Li, L. AU - Wei, M. PY - 2006 DA - 2006// TI - Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress JO - Can J Physiol Pharmacol VL - 84 UR - https://doi.org/10.1139/y06-075 DO - 10.1139/y06-075 ID - Xu2006 ER - TY - JOUR AU - Yokozawa, T. AU - Kang, K. S. AU - Park, C. H. AU - Noh, J. S. AU - Yamabe, N. AU - Shibahara, N. AU - Tanaka, T. PY - 2010 DA - 2010// TI - Bioactive constituents of Corni Fructus: the therapeutic use of morroniside, loganin, and 7-O-galloyl-D-sedoheptulose as renoprotective agents in type 2 diabetes JO - Drug Discov Ther VL - 4 ID - Yokozawa2010 ER - TY - JOUR AU - Kajikawa, M. AU - Nakashima, A. AU - Fujimura, N. AU - Maruhashi, T. AU - Iwamoto, Y. AU - Iwamoto, A. AU - Matsumoto, T. AU - Oda, N. AU - Hidaka, T. AU - Kihara, Y. AU - Chayama, K. AU - Goto, C. AU - Aibara, Y. AU - Noma, K. AU - Takeuchi, M. AU - Matsui, T. AU - Yamagishi, S. AU - Higashi, Y. PY - 2015 DA - 2015// TI - Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function JO - Diabetes Care VL - 38 UR - https://doi.org/10.2337/dc14-1435 DO - 10.2337/dc14-1435 ID - Kajikawa2015 ER - TY - JOUR AU - Tahara, N. AU - Yamagishi, S. AU - Takeuchi, M. AU - Honda, A. AU - Tahara, A. AU - Nitta, Y. AU - Kodama, N. AU - Mizoguchi, M. AU - Kaida, H. AU - Ishibashi, M. AU - Hayabuchi, N. AU - Matsui, T. AU - Imaizumi, T. PY - 2012 DA - 2012// TI - Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc12-0087 DO - 10.2337/dc12-0087 ID - Tahara2012 ER -